Clinical Trial Update: Performance of 18F-FDG Micro-PET-CT in the Assessment of Surgical Margins in Head and Neck Cancer [NA]

View source ↗

Summary

This clinical trial update notes that recruitment is ongoing for a study evaluating 18F-FDG micro-PET-CT for assessing surgical margins in head and neck cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)

Snippet

Sponsor: Centre Henri Becquerel | Conditions: Head & Neck Cancer | NA | Status: RECRUITING